These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8854234)

  • 1. Errors in time in pharmacokinetic studies.
    Jia X; Nedelman JR
    J Biopharm Stat; 1996 Jul; 6(3):303-18. PubMed ID: 8854234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
    Kjellsson MC; Jönsson S; Karlsson MO
    AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation studies of errors of parameter estimates in pharmacokinetics.
    Betzien G; Kaufmann B; Schneider B; Ritschel WA
    Arzneimittelforschung; 1985; 35(1):7-14. PubMed ID: 3838673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuzzy least squares for identification of individual pharmacokinetic parameters.
    Seng KY; Nestorov I; Vicini P
    IEEE Trans Biomed Eng; 2009 Dec; 56(12):2796-805. PubMed ID: 19695981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
    Retout S; Mentré F; Bruno R
    Stat Med; 2002 Sep; 21(18):2623-39. PubMed ID: 12228881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
    Comets E; Brendel K; Mentré F
    Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
    Farenc C; Fabreguette JR; Bressolle F
    Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
    Dansirikul C; Choi M; Duffull SB
    Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated failure time models with covariates subject to measurement error.
    He W; Yi GY; Xiong J
    Stat Med; 2007 Nov; 26(26):4817-32. PubMed ID: 17436310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
    Proost JH; Schiere S; Eleveld DJ; Wierda JM
    Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma generalized linear models for pharmacokinetic data.
    Salway R; Wakefield J
    Biometrics; 2008 Jun; 64(2):620-6. PubMed ID: 17888039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.
    Tornøe CW; Agersø H; Jonsson EN; Madsen H; Nielsen HA
    Comput Methods Programs Biomed; 2004 Oct; 76(1):31-40. PubMed ID: 15313540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of approximating or ignoring within-study covariances in multivariate meta-analyses.
    Ishak KJ; Platt RW; Joseph L; Hanley JA
    Stat Med; 2008 Feb; 27(5):670-86. PubMed ID: 17492826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NONMEMory: a run management tool for NONMEM.
    Wilkins JJ
    Comput Methods Programs Biomed; 2005 Jun; 78(3):259-67. PubMed ID: 15899310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.